Global Gene Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Global Gene Therapy Market Size was estimated at USD 1643.21 million in 2023 and is projected to reach USD 7092.46 million by 2029, exhibiting a CAGR of 27.60% during the forecast period.
This report provides a deep insight into the global Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy market in any manner.
Global Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Therapy
Non-Viral Gene Therapy
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Global Gene Therapy Market Size was estimated at USD 1643.21 million in 2023 and is projected to reach USD 7092.46 million by 2029, exhibiting a CAGR of 27.60% during the forecast period.
This report provides a deep insight into the global Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy market in any manner.
Global Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Therapy
Non-Viral Gene Therapy
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene Therapy Market
- Overview of the regional outlook of the Gene Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy Sales Sites, Area Served, Product Type
3.6 Gene Therapy Market Competitive Situation and Trends
3.6.1 Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy Price by Type (2019-2024)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy Sales Growth Rate by Application (2019-2024)
8 GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Gene Therapy Basic Information
9.1.2 Biogen Gene Therapy Product Overview
9.1.3 Biogen Gene Therapy Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene Therapy SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene Therapy Basic Information
9.2.2 Novartis Gene Therapy Product Overview
9.2.3 Novartis Gene Therapy Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene Therapy SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene Therapy Basic Information
9.3.2 Gilead Sciences Gene Therapy Product Overview
9.3.3 Gilead Sciences Gene Therapy Product Market Performance
9.3.4 Gilead Sciences Gene Therapy SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene Therapy Basic Information
9.4.2 Sarepta Therapeutics Gene Therapy Product Overview
9.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene Therapy Basic Information
9.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
9.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene Therapy Basic Information
9.6.2 Amgen Gene Therapy Product Overview
9.6.3 Amgen Gene Therapy Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene Therapy Basic Information
9.7.2 Spark Therapeutics Gene Therapy Product Overview
9.7.3 Spark Therapeutics Gene Therapy Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene Therapy Basic Information
9.8.2 Akcea Therapeutics Gene Therapy Product Overview
9.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 bluebird bio
9.9.1 bluebird bio Gene Therapy Basic Information
9.9.2 bluebird bio Gene Therapy Product Overview
9.9.3 bluebird bio Gene Therapy Product Market Performance
9.9.4 bluebird bio Business Overview
9.9.5 bluebird bio Recent Developments
9.10 Sunway Biotech
9.10.1 Sunway Biotech Gene Therapy Basic Information
9.10.2 Sunway Biotech Gene Therapy Product Overview
9.10.3 Sunway Biotech Gene Therapy Product Market Performance
9.10.4 Sunway Biotech Business Overview
9.10.5 Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Gene Therapy Basic Information
9.11.2 SIBIONO Gene Therapy Product Overview
9.11.3 SIBIONO Gene Therapy Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Gene Therapy Basic Information
9.12.2 AnGes Gene Therapy Product Overview
9.12.3 AnGes Gene Therapy Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Gene Therapy Basic Information
9.13.2 Orchard Therapeutics Gene Therapy Product Overview
9.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
9.14 Human Stem Cells Institute
9.14.1 Human Stem Cells Institute Gene Therapy Basic Information
9.14.2 Human Stem Cells Institute Gene Therapy Product Overview
9.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
9.14.4 Human Stem Cells Institute Business Overview
9.14.5 Human Stem Cells Institute Recent Developments
10 GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Gene Therapy Market Size Forecast
10.2 Global Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
10.2.4 South America Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy by Type (2025-2030)
11.1.2 Global Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy by Type (2025-2030)
11.2 Global Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy Sales Sites, Area Served, Product Type
3.6 Gene Therapy Market Competitive Situation and Trends
3.6.1 Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy Price by Type (2019-2024)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy Sales Growth Rate by Application (2019-2024)
8 GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Gene Therapy Basic Information
9.1.2 Biogen Gene Therapy Product Overview
9.1.3 Biogen Gene Therapy Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene Therapy SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene Therapy Basic Information
9.2.2 Novartis Gene Therapy Product Overview
9.2.3 Novartis Gene Therapy Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene Therapy SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene Therapy Basic Information
9.3.2 Gilead Sciences Gene Therapy Product Overview
9.3.3 Gilead Sciences Gene Therapy Product Market Performance
9.3.4 Gilead Sciences Gene Therapy SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene Therapy Basic Information
9.4.2 Sarepta Therapeutics Gene Therapy Product Overview
9.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene Therapy Basic Information
9.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
9.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene Therapy Basic Information
9.6.2 Amgen Gene Therapy Product Overview
9.6.3 Amgen Gene Therapy Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene Therapy Basic Information
9.7.2 Spark Therapeutics Gene Therapy Product Overview
9.7.3 Spark Therapeutics Gene Therapy Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene Therapy Basic Information
9.8.2 Akcea Therapeutics Gene Therapy Product Overview
9.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 bluebird bio
9.9.1 bluebird bio Gene Therapy Basic Information
9.9.2 bluebird bio Gene Therapy Product Overview
9.9.3 bluebird bio Gene Therapy Product Market Performance
9.9.4 bluebird bio Business Overview
9.9.5 bluebird bio Recent Developments
9.10 Sunway Biotech
9.10.1 Sunway Biotech Gene Therapy Basic Information
9.10.2 Sunway Biotech Gene Therapy Product Overview
9.10.3 Sunway Biotech Gene Therapy Product Market Performance
9.10.4 Sunway Biotech Business Overview
9.10.5 Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Gene Therapy Basic Information
9.11.2 SIBIONO Gene Therapy Product Overview
9.11.3 SIBIONO Gene Therapy Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Gene Therapy Basic Information
9.12.2 AnGes Gene Therapy Product Overview
9.12.3 AnGes Gene Therapy Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Gene Therapy Basic Information
9.13.2 Orchard Therapeutics Gene Therapy Product Overview
9.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
9.14 Human Stem Cells Institute
9.14.1 Human Stem Cells Institute Gene Therapy Basic Information
9.14.2 Human Stem Cells Institute Gene Therapy Product Overview
9.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
9.14.4 Human Stem Cells Institute Business Overview
9.14.5 Human Stem Cells Institute Recent Developments
10 GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Gene Therapy Market Size Forecast
10.2 Global Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
10.2.4 South America Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy by Type (2025-2030)
11.1.2 Global Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy by Type (2025-2030)
11.2 Global Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2022)
Table 10. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy Product Type
Table 13. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy Market Challenges
Table 22. Global Gene Therapy Sales by Type (K Units)
Table 23. Global Gene Therapy Market Size by Type (M USD)
Table 24. Global Gene Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Gene Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gene Therapy Sales (K Units) by Application
Table 30. Global Gene Therapy Market Size by Application
Table 31. Global Gene Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Biogen Gene Therapy Basic Information
Table 44. Biogen Gene Therapy Product Overview
Table 45. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Gene Therapy SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Gene Therapy Basic Information
Table 50. Novartis Gene Therapy Product Overview
Table 51. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Gilead Sciences Gene Therapy Basic Information
Table 56. Gilead Sciences Gene Therapy Product Overview
Table 57. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Gene Therapy SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. Sarepta Therapeutics Gene Therapy Basic Information
Table 62. Sarepta Therapeutics Gene Therapy Product Overview
Table 63. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sarepta Therapeutics Business Overview
Table 65. Sarepta Therapeutics Recent Developments
Table 66. Alnylam Pharmaceuticals Gene Therapy Basic Information
Table 67. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Recent Developments
Table 71. Amgen Gene Therapy Basic Information
Table 72. Amgen Gene Therapy Product Overview
Table 73. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Amgen Business Overview
Table 75. Amgen Recent Developments
Table 76. Spark Therapeutics Gene Therapy Basic Information
Table 77. Spark Therapeutics Gene Therapy Product Overview
Table 78. Spark Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Spark Therapeutics Business Overview
Table 80. Spark Therapeutics Recent Developments
Table 81. Akcea Therapeutics Gene Therapy Basic Information
Table 82. Akcea Therapeutics Gene Therapy Product Overview
Table 83. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Akcea Therapeutics Business Overview
Table 85. Akcea Therapeutics Recent Developments
Table 86. bluebird bio Gene Therapy Basic Information
Table 87. bluebird bio Gene Therapy Product Overview
Table 88. bluebird bio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. bluebird bio Business Overview
Table 90. bluebird bio Recent Developments
Table 91. Sunway Biotech Gene Therapy Basic Information
Table 92. Sunway Biotech Gene Therapy Product Overview
Table 93. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sunway Biotech Business Overview
Table 95. Sunway Biotech Recent Developments
Table 96. SIBIONO Gene Therapy Basic Information
Table 97. SIBIONO Gene Therapy Product Overview
Table 98. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. SIBIONO Business Overview
Table 100. SIBIONO Recent Developments
Table 101. AnGes Gene Therapy Basic Information
Table 102. AnGes Gene Therapy Product Overview
Table 103. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. AnGes Business Overview
Table 105. AnGes Recent Developments
Table 106. Orchard Therapeutics Gene Therapy Basic Information
Table 107. Orchard Therapeutics Gene Therapy Product Overview
Table 108. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Orchard Therapeutics Business Overview
Table 110. Orchard Therapeutics Recent Developments
Table 111. Human Stem Cells Institute Gene Therapy Basic Information
Table 112. Human Stem Cells Institute Gene Therapy Product Overview
Table 113. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Human Stem Cells Institute Business Overview
Table 115. Human Stem Cells Institute Recent Developments
Table 116. Global Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Gene Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Gene Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Gene Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2022)
Table 10. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy Product Type
Table 13. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy Market Challenges
Table 22. Global Gene Therapy Sales by Type (K Units)
Table 23. Global Gene Therapy Market Size by Type (M USD)
Table 24. Global Gene Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Gene Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gene Therapy Sales (K Units) by Application
Table 30. Global Gene Therapy Market Size by Application
Table 31. Global Gene Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Biogen Gene Therapy Basic Information
Table 44. Biogen Gene Therapy Product Overview
Table 45. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Gene Therapy SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Gene Therapy Basic Information
Table 50. Novartis Gene Therapy Product Overview
Table 51. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Gilead Sciences Gene Therapy Basic Information
Table 56. Gilead Sciences Gene Therapy Product Overview
Table 57. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Gene Therapy SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. Sarepta Therapeutics Gene Therapy Basic Information
Table 62. Sarepta Therapeutics Gene Therapy Product Overview
Table 63. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sarepta Therapeutics Business Overview
Table 65. Sarepta Therapeutics Recent Developments
Table 66. Alnylam Pharmaceuticals Gene Therapy Basic Information
Table 67. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Recent Developments
Table 71. Amgen Gene Therapy Basic Information
Table 72. Amgen Gene Therapy Product Overview
Table 73. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Amgen Business Overview
Table 75. Amgen Recent Developments
Table 76. Spark Therapeutics Gene Therapy Basic Information
Table 77. Spark Therapeutics Gene Therapy Product Overview
Table 78. Spark Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Spark Therapeutics Business Overview
Table 80. Spark Therapeutics Recent Developments
Table 81. Akcea Therapeutics Gene Therapy Basic Information
Table 82. Akcea Therapeutics Gene Therapy Product Overview
Table 83. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Akcea Therapeutics Business Overview
Table 85. Akcea Therapeutics Recent Developments
Table 86. bluebird bio Gene Therapy Basic Information
Table 87. bluebird bio Gene Therapy Product Overview
Table 88. bluebird bio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. bluebird bio Business Overview
Table 90. bluebird bio Recent Developments
Table 91. Sunway Biotech Gene Therapy Basic Information
Table 92. Sunway Biotech Gene Therapy Product Overview
Table 93. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sunway Biotech Business Overview
Table 95. Sunway Biotech Recent Developments
Table 96. SIBIONO Gene Therapy Basic Information
Table 97. SIBIONO Gene Therapy Product Overview
Table 98. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. SIBIONO Business Overview
Table 100. SIBIONO Recent Developments
Table 101. AnGes Gene Therapy Basic Information
Table 102. AnGes Gene Therapy Product Overview
Table 103. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. AnGes Business Overview
Table 105. AnGes Recent Developments
Table 106. Orchard Therapeutics Gene Therapy Basic Information
Table 107. Orchard Therapeutics Gene Therapy Product Overview
Table 108. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Orchard Therapeutics Business Overview
Table 110. Orchard Therapeutics Recent Developments
Table 111. Human Stem Cells Institute Gene Therapy Basic Information
Table 112. Human Stem Cells Institute Gene Therapy Product Overview
Table 113. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Human Stem Cells Institute Business Overview
Table 115. Human Stem Cells Institute Recent Developments
Table 116. Global Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Gene Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Gene Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Gene Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Gene Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Gene Therapy by Type in 2023
Figure 20. Market Size Share of Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy Market Share by Application
Figure 24. Global Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Gene Therapy Market Share by Application in 2023
Figure 28. Global Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gene Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 50. South America Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gene Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Gene Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Gene Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Gene Therapy by Type in 2023
Figure 20. Market Size Share of Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy Market Share by Application
Figure 24. Global Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Gene Therapy Market Share by Application in 2023
Figure 28. Global Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gene Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 50. South America Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gene Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Gene Therapy Market Share Forecast by Application (2025-2030)
